NOVARTIS PHARMACEUTICALS v. ACCORD HEALTHCARE INC.
Before Moore, Linn, and O’Malley. Appeal from the United States District Court for the District of Delaware.
Summary: A patent application that was silent about a...more
1/5/2022
/ Appeals ,
Generic Drugs ,
Intellectual Property Protection ,
Novartis ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Written Descriptions
BELCHER PHARMACEUTICALS v. HOSPIRA, INC.
Before Reyna, Taranto, and Stoll. Appeal from the District of Delaware.
Summary: A patentee committed inequitable conduct by advancing an argument during patent prosecution...more
9/2/2021
/ Failure To Disclose ,
Hatch-Waxman ,
Hospira ,
Inequitable Conduct ,
Intellectual Property Protection ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Prosecution ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art
PERSION PHARMACEUTICALS LLC v. ALVOGEN MALTA OPERATIONS LTD.
Before O’Malley, Reyna, and Chen. Appeal from the U.S. District Court for the District of Delaware.
Summary: The FDA’s acceptance of safety data for a...more
12/30/2019
/ Appeals ,
Evidence ,
FDA Approval ,
Motivation to Combine ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Reaffirmation
BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC -
Before Wallach, Moore, and Chen. Consolidated appeals from the Patent Trial and Appeal Board and the U.S. District Court for the District of New...more
Federal Circuit Summary -
Before Moore, Reyna, and Wallach. Appeal from the Southern District of California.
Summary: District court improperly held that claims were directed to a natural law where the claims recited a...more
Federal Circuit Summaries -
Before Newman, Dyk, and Chen. Appeal from the Patent Trial and Appeal Board.
Summary: An injury-in-fact is required to establish Article III standing for judicial review of agency action,...more
2/12/2019
/ Appeals ,
Article III ,
Biosimilars ,
Clinical Trials ,
Estoppel ,
Injury-in-Fact ,
Inter Partes Review (IPR) Proceeding ,
Mootness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Standing